The Journal of Nutritional Biochemistry
Volume 18, Issue 10 , Pages 658-666 , October 2007

Conjugated linoleic acid supplementation reduces peripheral blood mononuclear cell interleukin-2 production in healthy middle-aged males

  • Anne Mullen

      Affiliations

    • Nutrigenomics Research Group, Department of Clinical Medicine and Institute of Molecular Medicine, St. James's Hospital, Dublin 8, Ireland
    • ,
  • Fiona Moloney

      Affiliations

    • Nutrigenomics Research Group, Department of Clinical Medicine and Institute of Molecular Medicine, St. James's Hospital, Dublin 8, Ireland
    • ,
  • Anne P. Nugent

      Affiliations

    • Nutrigenomics Research Group, Department of Clinical Medicine and Institute of Molecular Medicine, St. James's Hospital, Dublin 8, Ireland
    • ,
  • Lorna Doyle

      Affiliations

    • Department of Food and Nutritional Sciences, Biosciences Institute, University College, Cork, Ireland
    • ,
  • Kevin D. Cashman

      Affiliations

    • Department of Food and Nutritional Sciences, Biosciences Institute, University College, Cork, Ireland
    • ,
  • Helen M. Roche

      Affiliations

    • Nutrigenomics Research Group, Department of Clinical Medicine and Institute of Molecular Medicine, St. James's Hospital, Dublin 8, Ireland
    • Corresponding Author InformationCorresponding author. Department of Clinical Medicine, Trinity Centre for Health Sciences, St. James's Hospital, Dublin 8, Ireland.

Received 5 May 2006 ,Revised 7 November 2006 ,Accepted 20 December 2006.

References 

  1. Kepler CR, Hirons KP, McNeill JJ, Tove SB. Intermediates and products of the biohydrogenation of linoleic acid by butyrivibrio fibrisolvens. J Biol Chem. 1996;241:1350–1354
  2. Chin SD, Liu W, Storkson JM, Ha YL, Pariza MW. Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognised class of anticarcinogens. J Food Comp Anal. 1992;5:185–197
  3. Kramer JK, Parodi PW, Jensen RG, Mossoba MM, Yurawecz MP, Adolf RO. Rumenic acid: a proposed common name for the major conjugated linoleic acid isomer found in natural products. Lipids. 1997;33:835
  4. Parodi PW. Cows' milk fat components as potential anticarcinogenic agents. J Nutr. 1997;127:1055–1060
  5. Banni S, Martin JC. Conjugated linoleic acid and metabolites. In:  Sebedio JL,  Christie WW editor. Trans fatty acids in human nutrition. Aberdeen: Oily Press; 1998;p. 261–302
  6. Ip C, Chin SF, Scimeca JA, Pariza MW. Mammary cancer prevention by conjugated dienoic derivative of linoleic acid. Cancer Res. 1991;51:6118–6124
  7. Banni S, Angioni E, Casu V, Melis MP, Carta G, Corongiu FP, et al. Decrease in linoleic acid metabolites as a potential mechanism in cancer risk reduction by conjugated linoleic acid. Carcinogenesis. 1999;20:1019–1024
  8. Field CJ, Schley PD. Evidence for potential mechanisms for the effect of conjugated linoleic acid on tumor metabolism and immune function: lessons from n-3 fatty acids. Am J Clin Nutr. 2004;79:1190S–1198S
  9. Houseknecht KL, Vanden Heuvel JP, Moya-Camarena SY, Portocarrero CP, Peck LW, Nickel KP, et al. Dietary conjugated linoleic acid normalises impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun. 1998;244:678–682
  10. Roche HM, Noone E, Sewter C, McBennett S, Savage D, Gibney MJ, et al. Isomer dependent metabolic effects of conjugated linoleic acid (CLA), insights from molecular markers: SREBP-1c and LXRα. Diabetes. 2002;51(7):2037–2044
  11. Kritchevsky D, Tepper SA, Wright S, Tso P, Czarnecki SK. Influence of conjugated linoleic acid (CLA) on establishment and progression of atherosclerosis in rabbits. J Am Coll Nutr. 2002;19:472S–477S
  12. Toomey S, Roche H, Fitzgerald D, Belton O. Regression of pre-established atherosclerosis in the apoE−/− mouse by conjugated linoleic acid. Biochem Soc Trans. 2003;31:1075–1079
  13. Chew BP, Wong TS, Shultz TD, Magnuson NS. Effects of conjugated dienoic derivatives of linoleic acid and beta-carotene in modulating lymphocyte and macrophage function. Anticancer Res. 1997;17:1099–1106
  14. Hayek MG, Han SN, Wu D, Watkins BA, Medani M, Dorsey JL, et al. Dietary conjugated linoleic acid influences the immune response of young and old C57BL/6NCrlBR mice. J Nutr. 1999;129:32–38
  15. Cook ME, Miller CC, Park Y, Pariza M. Immune modulation by altered nutrient metabolism: nutritional control of immune-induced growth depression. Poult Sci. 1993;72:1301–1305
  16. Miller CC, Park Y, Pariza MW, Cook ME. Feeding conjugated linoleic acid to animals partially overcomes catabolic responses due to endotoxin injection. Biochem Biophys Res Commun. 1994;198:1107–1112
  17. Turek JJ, Li Y, Schoenlein IA, Allen KGD, Watkins BA. Modulation of macrophage cytokine production by conjugated linoleic acids is influenced by the dietary n-6:n-3 fatty acid ratio. J Nutr Biochem. 1998;9:258–266
  18. Zhao L, Yin J, Li D, Lai C, Chen X, Ma D. Conjugated linoleic acid can prevent tumor necrosis factor gene expression by inhibiting nuclear factor binding activity in peripheral blood mononuclear cells from weaned pigs challenged with lipopolysaccharide. Arch Anim Nutr. 2005;59:429–438
  19. Roche HM, Noone E, Nugent A, Gibney MJ. Conjugated linoleic acid: a novel therapeutic nutrient?. Nutr Res Rev. 2001;14:173–187
  20. O'Shea M, Bassaganya-Riera J, Mohede IC. Immunomodulatory properties of conjugated linoleic acid. Am J Clin Nutr. 2004;79:1199S–1206S
  21. Wahle KW, Heys SD, Rotondo D. Conjugated linoleic acids: are they beneficial or detrimental to health?. Prog Lipid Res. 2004;43:553–587
  22. Kelley DS, Taylor PC, Rudolph IL, Benito P, Nelson GJ, Mackey BE, et al. Dietary conjugated linoleic acid did not alter immune status in young healthy women. Lipids. 2000;35:1065–1071
  23. Kelley DS, Simon VA, Taylor PC, Rudolph IL, Benito P, Nelson GJ, et al. Dietary supplementation with conjugated linoleic acid increased its concentration in human peripheral blood mononuclear cells, but did not alter their function. Lipids. 2001;36:669–674
  24. Albers R, van der Wielen RPJ, Brink EJ, Hendriks HFJ, Dorovska-Taran VN, Mohede ICM. Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men. Eur J Clin Nutr. 2003;57:595–603
  25. Tricon S, Burdge GC, Kew S, Banerjee T, Russell JJ, Grimble RF, et al. Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid on immune cell function in healthy humans. Am J Clin Nutr. 2004;80:1626–1633
  26. Nugent AP, Roche HM, Noone EJ, Long A, Kelleher D, Gibney MJ. The effects of conjugated linoleic acid supplementation on immune function in healthy volunteers. Eur J Clin Nutr. 2005;59:742–750
  27. Wu D, Marko M, Claycombe K, Paulson KE, Meydani SN. Ceramide-induced and age-associated increase in macrophage COX-2 expression is mediated through up-regulation of NF-kappa B activity. J Biol Chem. 2003;278:10983–10992
  28. Hamer DH, Meydani SN. Immune function in the elderly. Arch Intern Med. 2001;161:482–483
  29. Holland B, Welch AA, Unwin ID, Buss DH, Paul AA, Southgate DAT. McCance and Widdowson's The Composition of Foods. 5th ed.. Cambridge: Royal Society of Chemistry; 1991;
  30. Fremann D, Linseisen J, Wolfram G. Dietary conjugated linoleic acid (CLA) intake assessment and possible biomarkers of CLA intake in young women. Public Health Nutr. 2002;5:73–80
  31. Ens JG, Ma DW, Cole KS, Field CJ, Clandinin MT. An assessment of c9,t11 linoleic acid intake in a small group of young Canadians. Nutr Res. 2001;21:955–960
  32. Ritzenthaler KL, McGuire MK, Falen R, Shultz TD, Dasgupta N, McGuire MA. Estimation of conjugated linoleic acid intake by written dietary assessment methodologies underestimates actual intake evaluated by food duplicate methodology. J Nutr. 2001;131:1548–1554
  33. Villegas R, Salim A, Collins MM, Flynn A, Perry U. Dietary patterns in middle-aged Irish men and women defined by cluster analysis. Public Health Nutr. 2004;7:1017–1024
  34. Yaqoob P, Pala HS, Cortina-Boria M, Newsholme EA, Calder PC. Encapsulated fish oil enriched in α-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. Eur J Clin Invest. 2000;30:260–274
  35. Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC. Dietary supplementation with gamma-linoleic acid or fish oil decreases T lymphocyte proliferation in healthy older humans. J Nutr. 2001;131:1918–1927
  36. Yaqoob P, Newsholme EA, Calder PC. Comparison of cytokine production in cultures of whole human blood and purified mononuclear cells. Cytokine. 1999;11:600–605
  37. Kew S, Banerjee T, Minihane AM, Finnegan YE, Williams CM, Calder PC. Relation between the fatty acid composition of peripheral blood mononuclear cells and measures of immune cell function in healthy, free-living subjects aged 25–72y. Am J Clin Nutr. 2003;77:1278–1286
  38. Dooper MMBW, Wassink K, M'Rabet L, Graus YMF. The modulatory effects of prostaglandin E in cytokine production by human peripheral blood mononuclear are independent of the prostaglandin subtype. Immunology. 2002;107:152–159
  39. Giddings JC. Hereditary coagulation disorders. Laboratory techniques. In:  Thomson JM editors. A practical guide to blood coagulation and haemostasis. London: Churchill Livingstone; 1980;p. 117
  40. Noone EJ, Roche HM, Nugent AP, Gibney MJ. The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br J Nutr. 2002;88:243–251
  41. Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497–509
  42. Mazzone A, De Servi S, Vezzoli M, Fossati G, Mazzucchelli I, Gritti D, et al. Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease. Atherosclerosis. 1999;145:369–374
  43. Okopien B, Krysiak R, Kowalski J, Madej A, Belowski D, Zielinski M, et al. The effect of statins and fibrates on interferon-gamma and interleukin-2 release in patients with primary type II dyslipidemia. Atherosclerosis. 2005;176:327–335
  44. Upadhya S, Mooteri S, Peckham N, Pai RG. Atherogenic effects of interleukin-2 and antiatherogenic effect of interleukin-2 antibody in apo-E deficient mice. Angiology. 2004;55:289–294
  45. Nabata T, Fukuo K, Morimoto S, Kitano S, Momose N, Hirotani A, et al. Interleukin-2 modulates the responsiveness to angiotensin II in cultured vascular smooth muscle cells. Atherosclerosis. 1997;133:23–30
  46. Moccellin S, Marincola F, Rossi CR, Nitti D, Lise M. The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. Cytokine Growth Factor Rev. 2004;15:61–76
  47. DePalma RG, Hayes VW, Cafferata HT, Mohammadpour HA, Chow BK, Zacharski LR, et al. Cytokine signatures in atherosclerotic claudicants. J Surg Res. 2003;111:215–221
  48. Hontecillas R, Wannemeulher MJ, Zimmerman DR, Hutto DL, Wilson JH, Ahn DU, et al. Nutritional regulation of porcine bacterial-induced colitis by conjugated linoleic acid. J Nutr. 2002;132:2019–2027
  49. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med. 1994;45:491–503
  50. Rerkasem K, Shearman CP, Williams JA, Morris GE, Phillips MJ, Calder PC, et al. C-Reactive protein is elevated in symptomatic compared with asymptomatic patients with carotid artery disease. Eur J Vasc Endovasc Surg. 2002;23:505–509
  51. Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham coronary heart disease risk score. Circulation. 2003;108:161–165
  52. Burdge GC, Lupoli B, Russel JJ, Tricon S, Kew S, Banerjee T, et al. Incorporation of cis-9, trans-11 or trans-10, cis-12 conjugated linoleic acid into plasma and cellular lipids in healthy men. J Lipid Res. 2004;45:736–741
  53. Licastro F, Davis LJ, Morini MC. Lectins and superantigens: membrane interactions of these compounds with T lymphocytes affect immune responses. Int J Biochem. 1993;25:845–852
  54. Jason J, Inge KL. The effects of mitogens, IL-2 and anti-CD3 antibody on the T-cell receptor Vβ repertoire. Scand J Immunol. 1996;43:652–661
  55. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis. 2000;148:209–214
  56. Yu Y, Correll PH, Vanden Heuvel JP. Conjugated linoleic acid decreases production of pre-inflammatory products in macrophage: evidence for a PPARγ-dependent mechanism. Biochim Biophys Acta. 2002;1581:89–99
  57. Moloney F, Yeow TP, Mullen A, Nolan JJ, Roche HM. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am J Clin Nutr. 2004;80:887–895
  58. Riserus U, Basu S, Jovinge S, Fredrikson GN, Arnlov J, Vessby B. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation. 2002;106:1925–1929
  59. Madsen T, Skou HA, Hansen VE, Fog L, Christensen JH, Toft E, et al. C-Reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol. 2001;88:1319–1342
  60. Smedman A, Basu S, Jovinge S, Fredrikson GN, Vessby B. Conjugated linoleic acid increased C-reactive protein in human subjects. Br J Nutr. 2005;94:791–795
  61. Ramakers JD, Plat J, Sebedio JL, Mensink RP. Effects of the individual cis-9, trans-11 us. Trans-10, cis-12 of conjugated linoleic acid (CLA) on inflammation parameters in moderately overweight subjects with LDL-phenotype B. Lipids. 2005;40:909–918
  62. Vickers MA, Green FR, Terry C, Mayosi BM, Julier C, Lathrop M, et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res. 2002;53:1029–1034
  63. Bennet AM, Prince JA, Fei GZ, Lyrenas L, Huang Y, Wiman B, et al. Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis. 2003;171:359–367
  64. Tricon S, Burdge GC, Jones EL, Russell JJ, El-Khazen S, Moretti E, et al. Effects of dairy products naturally enriched with cis-9, trans-11 conjugated linoleic acid on the blood lipid profile in healthy middle-aged men. Am J Clin Nutr. 2006;83:744–753
  65. Benito P, Nelson GJ, Kelley DS, Barolini G, Schmidt PC, Simon V. The effect of conjugated linoleic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids. 2001;36:229–326
  66. Desroches S, Chouinard PY, Galibois I, Corneau L, Delisle J, Lamarche B, et al. Lack of effect of dietary conjugated linoleic acids naturally incorporated into butter on the lipid profile and body composition of overweight and obese men. Am J Clin Nutr. 2005;82:309–319
  67. Naumann E, Carpentier YA, Saebo A, Lassel TS, Chardigny JM, Sebedio JL, et al. Cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) do not affect the plasma lipoprotein profile in moderately overweight subjects with LDL-phenotype B. Atherosclerosis. 2006;188:167–174
  68. Belury MA. Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annu Rev Nutr. 2002;22:505–531
  69. Song HJ, Sneddon AA, Heys SD, Wahle KW. Induction of apoptosis and inhibition of NF-kappaB activation in human prostate cancer cells by the cis-9, trans-11 but not the trans-10, cis-12 isomer of conjugated linoleic acid. Prostate. 2006;66:839–846
  70. Hwang DM, Kundu JK, Shin JW, Lee HJ, Surh YJ. Cis-9, trans-11 Conjugated linoleic acid down-regulates phorbol ester-induced NF-{kappa}B activation and subsequent COX-2 expression in hairless mouse skin by targeting I{kappa}B kinase and P13K-Akt. Carcinogenesis. 2007;28:363–371
  71. Shah SA, Mahmud N, Mftah M, Roche HM, Kelleher D. Chronic but not acute conjugated linoleic acid treatment inhibits deoxycholic acid-induced protein kinase C and nuclear factor-kappa B activation in human colorectal cancer cells. Eur J Cancer Prev. 2006;15:125–133
  72. Loscher CE, Draper E, Leavy O, Kelleher D, Mills KH, Roche HM. Conjugated linoleic acid suppresses NF-kappa B activation and IL-12 production in dendritic cells through ERK-mediated IL-10 induction. J Immunol. 2005;175:4990–4998

☆ Supported by the Irish Government's National Development Plan, Food Institutional Research Measure (FIRM), Department of Agriculture, Food and Rural Development. Conjugated linoleic acid supplements provided by Loders Croklan, Wormeveer, the Netherlands.

PII: S0955-2863(07)00008-3

doi: 10.1016/j.jnutbio.2006.12.008

The Journal of Nutritional Biochemistry
Volume 18, Issue 10 , Pages 658-666 , October 2007

Article Tools

* Image Usage & Resolution